Viewing Study NCT05598099



Ignite Creation Date: 2024-05-06 @ 6:14 PM
Last Modification Date: 2024-10-26 @ 2:44 PM
Study NCT ID: NCT05598099
Status: RECRUITING
Last Update Posted: 2022-10-28
First Post: 2022-10-24

Brief Title: Concentrated Exposure Therapy for Post-traumatic Stress Disorder - a Cohort Study
Sponsor: Haukeland University Hospital
Organization: Haukeland University Hospital

Study Overview

Official Title: Concentrated Exposure Therapy for Post-traumatic Stress Disorder - a Cohort Study
Status: RECRUITING
Status Verified Date: 2022-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Post-traumatic stress disorder PTSD is a prevalent and disabling condition Trauma-focused psychotherapy including cognitive behavioural therapy CBT are among the recommended first-line treatment alternatives However a substantial proportion of patients decline drop-out or do not respond to current psychotherapies Previous research suggests that intensive or concentrated formats of trauma-focused psychotherapy can lead to faster recover and lower attrition but there are currently few studies of these approaches The current study will investigate the acceptability treatment satisfaction and preliminary changes in symptoms after four consecutive days of concentrated CBT for PTSD
Detailed Description: The study will investigate the research questions in three stages In the first stage four patients will be treated individually In the second stage two groups of four patients will be treated with at least a 11 ratio between therapists and patients per group In the third stage 30 patients will be treated in groups of about four patients per group with at least a 11 ratio between therapists and patients per group The primary outcome measure is changes in PTSD-related symptoms as measured using the Clinician-Administered PTSD Scale for DSM-5 CAPS-5 Acceptability will be measured as the proportion of patients accepting treatment when offered while attrition is measured as the proportion of patients that withdraw from treatment after it has started Several other measures will be collected to measure treatment satisfaction related symptoms and functional impairment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None